INFECCIONES BACTERIANAS EN PACIENTES CON COVID-19 INGRESADOS EN EL HRE – IPS

Abstract

The COVID-19 pandemic constitutes an unprecedented challenge in all aspects of health care, also in the effective use of antibiotics and management of bacterial infections (Fernandez et al., 2020). Initial evidence shows that secondary bacterial infections, are important risk factor for adverse COVID-19 outcomes (IECS, 2020; PAHO,2021). Admission of patients to the HRE - IPS has clinical implications. Borrowing from experiences in other patient populations, it cannot be excluded a priori that early and late superinfections may be profoundly different in terms of risk. However, early and late superinfections are often lumped together in the currently available literature on patients with COVID-19, making it difficult to firmly understand their separate risks (Brassetti et al., 2020). Therefore, we sought to know the incidence of bacterial infections in patients with COVID-19, admitted to the HRE - IPS, period June, July and August 2021. A prospective cross-sectional observational study was chosen, with non-probabilistic intentional - consecutive sampling (by convenience), since the sample corresponded to all patients admitted to the HRE - IPS for COVID-19. It was found that the highest frequency of processed samples were blood cultures, in which the microorganism recovered from them was Staphylococcus haemolyticus producing Beta-lactamase. The microorganism with the highest isolation was Acinetobacter baumannii complex/haemolyticus, in second place, with equal frequency to Escherichia coli and Staphylococcus haemolyticus and, in third place, to Klebsiella pneumoniae with samples. Acinetobacter baumannii and Klebsiella pneumoniae showed marked resistance to Carbapenems. The timely detection of microorganisms producing resistance mechanisms is of utmost importance and constitutes one of the pillars for the containment of their propagation. Finally, it is necessary to update and raise awareness of the problem in the context of epidemiological surveillance, also the information of resistance and the analysis of the quality of medical care with the appropriate use of antimicrobials are priorities in the confrontation of this health problem in the HRE - IPS.